ABTA National Conference Expands Access to Emerging Science and Treatment Information

ABTA National Conference Expands Access to Emerging Science and Treatment Information

The 2020 American Brain Tumor Association National Conference is the largest conference designed for patients, survivors and caregivers impacted by a brain tumor diagnosis. Held annually and attended by more than 600 participants in previous years, the 2020 ABTA National Conference expands access to patients, caregivers and families to critical information in a free live webcast.

This virtual format helps to protect the health and safety of attendees during the COVID-19 pandemic.

Access to Transformative Brain Tumor Education

Held Friday, September 11 and Saturday, September 12, 10 AM – 5 PM CT, the National Conference convenes the nation’s leading brain tumor experts to provide the latest updates in brain tumor treatment, care and science. Through the generosity of The Sontag Foundation, the National Conference is completely free and now available for registration.

The conference will present 16 dynamic and interactive sessions to empower attendees across all stages of a brain tumor diagnosis. Each session provides attendees the opportunity to ask questions and get answers.

Sessions cover topics for those newly diagnosed, survivors and caregivers, including:  

    • Holistic Management of Brain Tumor Symptoms (including cannabis & nutrition)
    • Bench to Bedside: How Science Impacts Brain Tumor Patient Care
    • Practical Approaches to Diagnosis & Treatment of Brain Tumors
    • Looking Ahead: Research Updates
    • Living with a Brain Tumor: Patient & Caregiver Panel

View the full program to learn more. 

Designed and Presented by National Experts

Co-chairs of the 2020 ABTA National ConferenceThis interactive and informative conference is co-chaired by Mark Gilbert, MD of the National Cancer Institute, National Institutes of Health and Jean Arzbaecher, RN, APN, CNRN of the University of Illinois at Chicago.

Leveraging decades of experience from research in malignant primary brain tumors to advanced practice in neuro-oncology, Dr. Gilbert and Ms. Arzbaecher have brought together national experts from top medical institutions, including the University of California, San Francisco; Duke University Medical Center; Massachusetts General Hospital, Harvard Medical School and many more.